Melanie Walter

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

Bart Keymeulen, Melanie Walter, Chantal Mathieu et al. · Diabetologia · 2010 · 310 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +12

Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients

Sarah C. Grünert, S. Müllerleile, Linda De Silva et al. · Orphanet Journal of Rare Diseases · 2013 · 185 citations · Full text

IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity

Melanie Walter, E. D. Albert, Matthias Conrad et al. · Diabetologia · 2003 · 107 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Epidemiology +8

Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: The German BABYDIAB study

M Schenker, Michael Hummel, Karin M. Ferber et al. · Diabetologia · 1999 · 97 citations · Full text

Autoimmune Disease, Diabetes, Genetic Epidemiology +7

Propionic acidemia: neonatal versus selective metabolic screening

Sarah C. Grünert, S. Müllerleile, L. de Silva et al. · Journal of Inherited Metabolic Disease · 2011 · 90 citations · Full text